OBJECTIVE: To investigate chromosomal errors detected by first polar body (PB) biopsy in relation to the nuclear maturity of the oocytes. DESIGN: Retrospective study. SETTING: Reproductive medicine unit. PATIENT(S): Eighty-seven cycles were examined by PB biopsy for aneuploidy. Indications were maternal age >or=38 years (49 cycles), repeated IVF failures (22 cycles), and others (16 cycles). INTERVENTION(S): First polar bodies were analyzed for the chromosomes 13, 16, 18, 21, and 22 in both in vivo and in vitro matured oocytes. Euploid oocytes were inseminated by intracytoplasmic sperm injection. MAIN OUTCOME MEASURE(S): Chromosomal status of the analyzed oocytes, development after intracytoplasmic sperm injection, pregnancy, and implantation rates. RESULT(S): In in vitro matured oocytes, the proportion of chromosomal abnormalities was higher than in in vivo matured oocytes (70% vs. 54%, P<.005), with complex abnormalities being the prevailing defect (62% vs. 40%, P<.001). Conversely, the presence of an extra chromatid or the lack of a chromatid was more frequent in in vivo than in in vitro matured oocytes (55% vs. 34%, P<.001). CONCLUSION(S): The low viability of in vitro matured oocytes from stimulated cycles could be related to a significantly higher proportion of chromosomal abnormalities compared with in vivo matured oocytes. Complex abnormalities, involving two or more chromosomes, gave the strongest contribution to the detected increase.
OBJECTIVE: To investigate chromosomal errors detected by first polar body (PB) biopsy in relation to the nuclear maturity of the oocytes. DESIGN: Retrospective study. SETTING: Reproductive medicine unit. PATIENT(S): Eighty-seven cycles were examined by PB biopsy for aneuploidy. Indications were maternal age >or=38 years (49 cycles), repeated IVF failures (22 cycles), and others (16 cycles). INTERVENTION(S): First polar bodies were analyzed for the chromosomes 13, 16, 18, 21, and 22 in both in vivo and in vitro matured oocytes. Euploid oocytes were inseminated by intracytoplasmic sperm injection. MAIN OUTCOME MEASURE(S): Chromosomal status of the analyzed oocytes, development after intracytoplasmic sperm injection, pregnancy, and implantation rates. RESULT(S): In in vitro matured oocytes, the proportion of chromosomal abnormalities was higher than in in vivo matured oocytes (70% vs. 54%, P<.005), with complex abnormalities being the prevailing defect (62% vs. 40%, P<.001). Conversely, the presence of an extra chromatid or the lack of a chromatid was more frequent in in vivo than in in vitro matured oocytes (55% vs. 34%, P<.001). CONCLUSION(S): The low viability of in vitro matured oocytes from stimulated cycles could be related to a significantly higher proportion of chromosomal abnormalities compared with in vivo matured oocytes. Complex abnormalities, involving two or more chromosomes, gave the strongest contribution to the detected increase.
Authors: David E Reichman; Joseph Politch; Elizabeth S Ginsburg; Catherine Racowsky Journal: J Assist Reprod Genet Date: 2010-04-28 Impact factor: 3.412
Authors: I Hammoud; F Vialard; M Bergere; M Albert; D Molina Gomes; M Adler; L Malagrida; M Bailly; R Wainer; J Selva Journal: J Assist Reprod Genet Date: 2012-08-14 Impact factor: 3.412
Authors: Catherine Dupont; Alexandra J Harvey; D Randall Armant; Mary B Zelinski; Carol A Brenner Journal: Cell Cycle Date: 2012-02-15 Impact factor: 4.534
Authors: L Gianaroli; M C Magli; G Cavallini; A Crippa; A Capoti; S Resta; F Robles; A P Ferraretti Journal: Hum Reprod Date: 2010-07-08 Impact factor: 6.918
Authors: M Cristina Magli; Markus Montag; Maria Köster; Luigi Muzi; Joep Geraedts; John Collins; Veerle Goossens; Alan H Handyside; Joyce Harper; Sjoerd Repping; Andreas Schmutzler; Katerina Vesela; Luca Gianaroli Journal: Hum Reprod Date: 2011-09-09 Impact factor: 6.918
Authors: K E Hemmings; D Maruthini; S Vyjayanthi; J E Hogg; A H Balen; B K Campbell; H J Leese; H M Picton Journal: Hum Reprod Date: 2013-01-18 Impact factor: 6.918